Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The
DAPADream
study
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
2015 ◽
Vol 13
(3)
◽
pp. 55-56
◽
Keyword(s):
Keyword(s):
Keyword(s):